Should You Buy Actinium Pharmaceuticals Inc (ATNM) Stock Thursday Morning?

Thursday, August 25, 2022 09:20 AM | InvestorsObserver Analysts

Mentioned in this article

Actinium Pharmaceuticals Inc (ATNM) is higher by Thursday morning, with the stock rising 2.75% in pre-market trading to 6.35. ATNM's short-term technical score of 76 indicates that the stock has traded more bullishly over the last month than 76% of stocks on the market. In the Biotechnology industry, which ranks 125 out of 146 industries, ATNM ranks higher than 83% of stocks. Actinium Pharmaceuticals Inc has risen 26.38% over the past month, closing at $4.88 on July 28. During this period of time, the stock fell as low as $4.81 and as high as $6.25. ATNM has an average analyst recommendation of Strong Buy. The company has an average price target of $31.67.

ATNM has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on ATNM!
Actinium Pharmaceuticals Inc has a Long-Term Technical rank of 69. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 31% of the market scoring higher. In the Biotechnology industry which is number 72 by this metric, ATNM ranks better than 72% of stocks.

Important Dates for Investors in ATNM:

-Actinium Pharmaceuticals Inc is set to release earnings on 11/10/2022. Over the last 12 months, the company has reported EPS of $-1.22. -We do not have a set dividend date for Actinium Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Actinium Pharmaceuticals Inc (ATNM)

Share this article: